Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · IEX Real-Time Price · USD
0.670
-0.015 (-2.19%)
Jul 26, 2024, 3:39 PM EDT - Market closed
Rapid Micro Biosystems Revenue
Rapid Micro Biosystems had revenue of $5.61M in the quarter ending March 31, 2024, with 11.44% growth. This brings the company's revenue in the last twelve months to $23.10M, up 28.25% year-over-year. In the year 2023, Rapid Micro Biosystems had annual revenue of $22.52M with 31.44% growth.
Revenue (ttm)
$23.10M
Revenue Growth
+28.25%
P/S Ratio
1.24
Revenue / Employee
$119,663
Employees
193
Market Cap
28.72M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 22.52M | 5.39M | 31.44% |
Dec 31, 2022 | 17.13M | -6.10M | -26.25% |
Dec 31, 2021 | 23.23M | 7.15M | 44.50% |
Dec 31, 2020 | 16.08M | -435.00K | -2.63% |
Dec 31, 2019 | 16.51M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accelerate Diagnostics | 12.17M |
Bolt Biotherapeutics | 11.32M |
Palatin Technologies | 5.90M |
Renalytix | 2.22M |
Longeveron | 978.00K |
RPID News
- 9 days ago - Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024 - GlobeNewsWire
- 3 months ago - Rapid Micro Biosystems Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024 - GlobeNewsWire
- 4 months ago - Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024 - GlobeNewsWire
- 4 months ago - Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum - GlobeNewsWire
- 5 months ago - Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance - GlobeNewsWire
- 5 months ago - Rapid Micro Biosystems to Participate in Upcoming Investor Conferences - GlobeNewsWire